ProCE Banner Activity

COVID-19: Which Drug, When, and Why? Antiviral Agents

Podcast Episodes
What is the role and timing of antiviral agents for COVID-19? Listen to expert insights on considerations for inpatient or outpatient use and use in different age groups.

Released: April 25, 2022

Expiration: April 24, 2023

No longer available for credit.

Share

Faculty

David A. Wohl

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

David A. Wohl, MD, has disclosed that he has received funds for research support from Gilead Sciences and Merck and consulting fees from Gilead Sciences, Janssen, Merck, and ViiV.